NGM Biopharmaceuticals Inc (NGM) has fallen -12.21% in a Week, Should You Hold?

Friday, September 22, 2023 01:26 PM | InvestorsObserver Analysts

Mentioned in this article

NGM Biopharmaceuticals Inc (NGM) has fallen -12.21% in a Week, Should You Hold?

NGM Biopharmaceuticals Inc (NGM) is near the bottom in its industry group according to InvestorsObserver. NGM gets an overall rating of 34. That means it scores higher than 34 percent of stocks. NGM Biopharmaceuticals Inc gets a 30 rank in the Biotechnology industry. Biotechnology is number 72 out of 148 industries.

NGM has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on NGM!

See Full NGM Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 34 would rank higher than 34 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With NGM Biopharmaceuticals Inc Stock Today?

NGM Biopharmaceuticals Inc (NGM) stock is trading at $1.15 as of 1:24 PM on Friday, Sep 22, an increase of $0.03, or 2.68% from the previous closing price of $1.12. The stock has traded between $1.11 and $1.17 so far today. Volume today is 272,565 compared to average volume of 337,451. Click Here to get the full Stock Report for NGM Biopharmaceuticals Inc stock.